IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease

Immunogenetics

Volumn 49, Issue 6, 1999, Pages 527-531

  Nemetz, Andrea ^a   Nosti Escanilla, M Pilar ^d   Molnár, Tamás ^b   Köpe, Adorján ^a   Kovács, Ágota ^c   Fehér, János ^a   Tulassay, Zsolt ^a   Nagy, Ferenc ^b   García González, M Asunción ^d   Peña, A Salvador ^d  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c Erzsebet Hospital   (Hungary)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Crohn's disease; Disease susceptibility; IL1B gene polymorphism; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; ENTERITIS; EXON; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SYMPTOM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ALLELES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0032899896     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050530     Document Type: Article

References (24)

1. Aeberhard P, Berchtold W, Riedtmann HJ, Stadelmann G (1996) Surgical recurrence of perforating and nonperforating Crohn's disease. Dis Colon Rectum 39:80-87
2. Bayless TM, Tokayer AZ, Polito II JM, Quaskey SA, Mellits ED, Harris ML (1996) Crohn's disease: concordance for site and clinical type in affected family members - potential hereditary influences. Gastroenterology 111:573-579
3. Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Peña AS (1995) Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102:379-83
4. Bouma G, Crusius JBA, García-González MA, Meijer BUGA, Hellemans HPR, Schreuder GMT, Meuwissen SGM, Peña AS (1999) Genetics of ulcerative colitis (UC). Further evidence for the definition of a subgroup using immunogenetic markers. Clin Exp Immunol 115:294-300
5. Bouma G, Poen AC, García-González MA, Schreuder GMT, Felt-Bersma RJF, Meuwissen SGM, Peña AS (1998) HLA- DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 47:451-455
6. Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Belaiche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A (1996) Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111:604-607
7. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1:450
8. Dukovich M, Severin JM, White SJ, Yamazaki S, Mizel SB (1986) Stimulation of fibroblast proliferation and prostaglandin production by purified recombinant murine interleukin 1. Clin Immunol Immunopathol 38:381-9
9. Endres S, Cannon JG, Ghorbani R, Dempsey RA, Sisson SD, Lonnemann G, Van der Meer JW, Wolff SM, Dinarello CA (1989) In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 19:2327-33
10. Gilberts EC, Greenstein AJ, Katsel P, Harpaz N, Greenstein RJ (1994) Molecular evidence for two forms of Crohn disease. Proc Natl Acad Sci USA 91:12721-4
11. Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, Bretagne JF, Semana G (1997) Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 92:1164-9
12. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterology (Suppl 170): 2-6; discussion 16-9
13. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106:637-42
14. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB (1994) Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 106:960-72
15. Orholm M, Munkholm P, Langholtz E, Neilsen OH, Sørensen TIA, Binder V (1991) Familial occurence of inflammatory bowel disease. N Engl J Med 324:84-88
16. Pociot F, Molvig J, Wogensen L, Worsaae H, J. N (1992) A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1 b secretion in vitro. Eur J Clin Invest 22:396-402
17. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-81
18. Roth M-P, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI (1989) Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 96:1016-1020
19. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP (1997) Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112:1845-53
20. Sachar DB, Andrews HA, Farmer RG, Pallone F, Peña AS, Prantera C, Rutgeerts P (1992) Proposed classification of patients subgroups in Crohn's disease. Working team report. Gastroenterol Int 5:141-154
21. Santtila S, Savinainen K, Hurme M (1998) Presence of the IL- 1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195-8
22. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199-202
23. Troncone R, Caputo N, Campanozzi A, Cucciardi M, Esposito V, Russo R, De Vizia B, Greco L, Cucchiara S (1997) Gut lavage IgG and interleukin 1 receptor antagonist: interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease. Gut 41:60-5
24. Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B (1988) Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990-996